Global Laboratory Centrifuge Market 2025-2035
Description
Laboratory Centrifuge Market Size, Share & Trends Analysis Report by Product Type (Devices, Microcentrifuge, Multipurpose Centrifuge, Floor-Based Centrifuge, Ultracentrifuge, and Accessories) by Application (Diagnostic, Microbiology, Genomics, Proteomics, Blood Component Separation, Others) and By End-User (Hospitals, Academic & Research Institutes, and Biotechnology & Pharmaceutical Companies) Forecast Period (2025-2035)
Industry Overview
Laboratory centrifuge market was valued at $2.1 billion in 2024 and is projected to reach $3.7 billion by 2035, growing at a CAGR of 5.4% during the forecast Period (2025-2035). The market growth is driven by factors such as the increasing prevalence of chronic and infectious diseases, rising R&D in the biotechnology and pharmaceutical sectors, and technological advancements like automation and energy-efficient models. Key drivers include a growing demand for medical research and diagnostics, government initiatives, and the expansion of cell and gene therapy manufacturing, which requires advanced separation and purification techniques.
Market Dynamics
Rising Demand for Clinical Diagnostics and Disease Testing
The increasing global burden of chronic and infectious diseases, such as cancer, cardiovascular disorders, and viral infections, is driving the demand for laboratory diagnostic testing. Hospitals, pathology laboratories, and research institutions are expanding their diagnostic capabilities to manage the rising testing volumes, thereby increasing the adoption of laboratory centrifuges for blood, plasma, and urine sample separation. Additionally, advancements in molecular diagnostics, such as PCR and next-generation sequencing (NGS), require precise centrifugation processes for sample preparation, further fueling market growth. The surge in point-of-care and decentralized testing, supported by public health programs and healthcare investments, continues to propel centrifuge demand globally.
Expansion of Biopharmaceutical and Life Sciences Research
Rapid advancements in biotechnology, genomics, proteomics, and cell biology research are significantly boosting the adoption of laboratory centrifuges. The growth of biopharmaceutical manufacturing, especially in vaccine development, cell and gene therapy, and biologics production, has created strong demand for high-capacity and refrigerated centrifuges. Centrifugation is essential for applications such as cell harvesting, protein purification, and viral vector processing. Moreover, pharmaceutical and biotechnology companies are investing heavily in R&D infrastructure, particularly in Asia-Pacific and North America, which supports market expansion. The rise of contract research and manufacturing organizations (CROs and CMOs) is also contributing to consistent centrifuge procurement to meet GMP-grade production and testing requirements.
Integration of Automation and Energy-Efficient Technologies
Technological innovation remains a key market driver, with manufacturers focusing on integrating automation, IoT connectivity, and digital monitoring capabilities into centrifuge systems. Automated centrifuges enable streamlined sample handling, remote monitoring, and reduced human error, aligning with laboratory modernization trends. Additionally, growing awareness of sustainability and energy efficiency has led to the introduction of centrifuges featuring low-power consumption and eco-friendly refrigerants. Safety-focused designs, such as sealed rotors and imbalance detection systems, are further encouraging replacement purchases among research and clinical facilities. These advancements collectively enhance operational efficiency and strengthen the long-term growth prospects of the global laboratory centrifuge market.
Market Segmentation
Among all product segments, multipurpose centrifuges are expected to lead the global laboratory centrifuge market with the largest share during the forecast period. Multipurpose centrifuges offer high versatility and are designed to handle a wide range of sample types and volumes, making them suitable for clinical diagnostics, research, and industrial applications. Their ability to accommodate various rotors, tubes, and adapters allows laboratories to conduct multiple applications such as blood component separation, cell harvesting, and protein purification using a single device. This adaptability, combined with their cost-effectiveness and advanced control systems, has made multipurpose centrifuges the most preferred choice across hospitals, research institutes, and pharmaceutical companies.
Biotechnology & Pharmaceutical Companies: A Key Segment in Market Growth
The biotechnology and pharmaceutical companies segment is projected to witness the fastest growth in the global laboratory centrifuge market. The expanding focus on biopharmaceutical production, including vaccines, monoclonal antibodies, and cell and gene therapies, has significantly increased the demand for high-performance centrifuges. These systems are essential in various stages of drug discovery, molecular biology, and production processes, including sample clarification, separation of biomolecules, and downstream purification. The continuous rise in R&D investments, coupled with the growing number of clinical trials worldwide, is further supporting this segment’s growth.
Moreover, the emergence of advanced therapeutics and personalized medicine has pushed pharmaceutical and biotech firms to enhance their laboratory infrastructure. As companies adopt automation and single-use technologies, modern centrifuge systems with digital interfaces and real-time monitoring capabilities are becoming standard in production and quality control environments. The rapid expansion of biomanufacturing facilities in regions like North America, Europe, and Asia-Pacific-especially in India, China, and South Korea continues to drive centrifuge demand from this end-user group.
Regional Outlook
The global laboratory centrifuge market is further divided by region, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Asia-Pacific Maintains Strong Market Position
In North America, the US dominates the global laboratory centrifuge market with a major share, driven by its highly developed healthcare infrastructure, advanced life sciences research ecosystem, and strong presence of leading market players. The country’s robust network of hospitals, diagnostic laboratories, academic research institutions, and biopharmaceutical companies ensures consistent demand for high-performance centrifugation systems. The US government and private sector continuously invest in biomedical research, precision medicine, and biotechnology innovation, which fuels the adoption of advanced centrifuges for clinical diagnostics, genomics, proteomics, and cell biology applications. Additionally, the rising prevalence of chronic and infectious diseases has amplified diagnostic testing volumes, further supporting market growth.
The US is also home to several global leaders such as Thermo Fisher Scientific, Beckman Coulter (Danaher Corporation), and Eppendorf North America, which offer a wide range of centrifugation solutions integrated with automation, digital monitoring, and sustainability features. These companies maintain a competitive edge through technological innovation, strategic collaborations, and extensive distribution networks. Furthermore, the presence of a strong regulatory framework by agencies such as the US Food and Drug Administration (FDA) ensures high-quality standards and accelerates the adoption of advanced laboratory instruments in both clinical and research settings.
Continuous R&D funding from organizations like the National Institutes of Health (NIH) and collaborations between academia and industry further enhance centrifuge utilization across genomics, molecular diagnostics, and biomanufacturing. The US also serves as a global hub for contract research and manufacturing organizations (CROs and CMOs), which rely on centrifugation technologies for drug discovery and production workflows.
Market Players Outlook
The major companies operating in the global laboratory centrifuge market include Andreas Hettich GmbH & Co. KG, Danaher Corp., Eppendorf AG, Sigma Laborzentrifugen GmbH, Ltd., Thermo Fisher Scientific Inc., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
Industry Overview
Laboratory centrifuge market was valued at $2.1 billion in 2024 and is projected to reach $3.7 billion by 2035, growing at a CAGR of 5.4% during the forecast Period (2025-2035). The market growth is driven by factors such as the increasing prevalence of chronic and infectious diseases, rising R&D in the biotechnology and pharmaceutical sectors, and technological advancements like automation and energy-efficient models. Key drivers include a growing demand for medical research and diagnostics, government initiatives, and the expansion of cell and gene therapy manufacturing, which requires advanced separation and purification techniques.
Market Dynamics
Rising Demand for Clinical Diagnostics and Disease Testing
The increasing global burden of chronic and infectious diseases, such as cancer, cardiovascular disorders, and viral infections, is driving the demand for laboratory diagnostic testing. Hospitals, pathology laboratories, and research institutions are expanding their diagnostic capabilities to manage the rising testing volumes, thereby increasing the adoption of laboratory centrifuges for blood, plasma, and urine sample separation. Additionally, advancements in molecular diagnostics, such as PCR and next-generation sequencing (NGS), require precise centrifugation processes for sample preparation, further fueling market growth. The surge in point-of-care and decentralized testing, supported by public health programs and healthcare investments, continues to propel centrifuge demand globally.
Expansion of Biopharmaceutical and Life Sciences Research
Rapid advancements in biotechnology, genomics, proteomics, and cell biology research are significantly boosting the adoption of laboratory centrifuges. The growth of biopharmaceutical manufacturing, especially in vaccine development, cell and gene therapy, and biologics production, has created strong demand for high-capacity and refrigerated centrifuges. Centrifugation is essential for applications such as cell harvesting, protein purification, and viral vector processing. Moreover, pharmaceutical and biotechnology companies are investing heavily in R&D infrastructure, particularly in Asia-Pacific and North America, which supports market expansion. The rise of contract research and manufacturing organizations (CROs and CMOs) is also contributing to consistent centrifuge procurement to meet GMP-grade production and testing requirements.
Integration of Automation and Energy-Efficient Technologies
Technological innovation remains a key market driver, with manufacturers focusing on integrating automation, IoT connectivity, and digital monitoring capabilities into centrifuge systems. Automated centrifuges enable streamlined sample handling, remote monitoring, and reduced human error, aligning with laboratory modernization trends. Additionally, growing awareness of sustainability and energy efficiency has led to the introduction of centrifuges featuring low-power consumption and eco-friendly refrigerants. Safety-focused designs, such as sealed rotors and imbalance detection systems, are further encouraging replacement purchases among research and clinical facilities. These advancements collectively enhance operational efficiency and strengthen the long-term growth prospects of the global laboratory centrifuge market.
Market Segmentation
- Based on the product type, the market is segmented into devices, microcentrifuges, multipurpose centrifuges, floor-based centrifuges, ultracentrifuges, and accessories.
- Based on the application, the market is segmented into diagnostic, microbiology, genomics, proteomics, blood component separation, and others.
- Based on the end-user, the market is segmented into hospitals, academic & research institutes, and biotechnology & pharmaceutical companies.
Among all product segments, multipurpose centrifuges are expected to lead the global laboratory centrifuge market with the largest share during the forecast period. Multipurpose centrifuges offer high versatility and are designed to handle a wide range of sample types and volumes, making them suitable for clinical diagnostics, research, and industrial applications. Their ability to accommodate various rotors, tubes, and adapters allows laboratories to conduct multiple applications such as blood component separation, cell harvesting, and protein purification using a single device. This adaptability, combined with their cost-effectiveness and advanced control systems, has made multipurpose centrifuges the most preferred choice across hospitals, research institutes, and pharmaceutical companies.
Biotechnology & Pharmaceutical Companies: A Key Segment in Market Growth
The biotechnology and pharmaceutical companies segment is projected to witness the fastest growth in the global laboratory centrifuge market. The expanding focus on biopharmaceutical production, including vaccines, monoclonal antibodies, and cell and gene therapies, has significantly increased the demand for high-performance centrifuges. These systems are essential in various stages of drug discovery, molecular biology, and production processes, including sample clarification, separation of biomolecules, and downstream purification. The continuous rise in R&D investments, coupled with the growing number of clinical trials worldwide, is further supporting this segment’s growth.
Moreover, the emergence of advanced therapeutics and personalized medicine has pushed pharmaceutical and biotech firms to enhance their laboratory infrastructure. As companies adopt automation and single-use technologies, modern centrifuge systems with digital interfaces and real-time monitoring capabilities are becoming standard in production and quality control environments. The rapid expansion of biomanufacturing facilities in regions like North America, Europe, and Asia-Pacific-especially in India, China, and South Korea continues to drive centrifuge demand from this end-user group.
Regional Outlook
The global laboratory centrifuge market is further divided by region, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Asia-Pacific Maintains Strong Market Position
In North America, the US dominates the global laboratory centrifuge market with a major share, driven by its highly developed healthcare infrastructure, advanced life sciences research ecosystem, and strong presence of leading market players. The country’s robust network of hospitals, diagnostic laboratories, academic research institutions, and biopharmaceutical companies ensures consistent demand for high-performance centrifugation systems. The US government and private sector continuously invest in biomedical research, precision medicine, and biotechnology innovation, which fuels the adoption of advanced centrifuges for clinical diagnostics, genomics, proteomics, and cell biology applications. Additionally, the rising prevalence of chronic and infectious diseases has amplified diagnostic testing volumes, further supporting market growth.
The US is also home to several global leaders such as Thermo Fisher Scientific, Beckman Coulter (Danaher Corporation), and Eppendorf North America, which offer a wide range of centrifugation solutions integrated with automation, digital monitoring, and sustainability features. These companies maintain a competitive edge through technological innovation, strategic collaborations, and extensive distribution networks. Furthermore, the presence of a strong regulatory framework by agencies such as the US Food and Drug Administration (FDA) ensures high-quality standards and accelerates the adoption of advanced laboratory instruments in both clinical and research settings.
Continuous R&D funding from organizations like the National Institutes of Health (NIH) and collaborations between academia and industry further enhance centrifuge utilization across genomics, molecular diagnostics, and biomanufacturing. The US also serves as a global hub for contract research and manufacturing organizations (CROs and CMOs), which rely on centrifugation technologies for drug discovery and production workflows.
Market Players Outlook
The major companies operating in the global laboratory centrifuge market include Andreas Hettich GmbH & Co. KG, Danaher Corp., Eppendorf AG, Sigma Laborzentrifugen GmbH, Ltd., Thermo Fisher Scientific Inc., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
- In March 2025, Thermo Fisher Scientific introduced sustainable large-capacity and superspeed centrifuges, replacing the Sorvall line. The Cryofuge, BIOS, and LYNX centrifuges are the first floor-model centrifuges with natural refrigerant cooling systems compliant with EU and EPA F-gas regulations. Thermo Scientific GreenCool Technology, a next-generation cooling system, is 1,397 times less impactful on the environment. The centrifuges are manufactured at a certified zero-waste facility in Germany, powered by 100% renewable energy.
- Market value data analysis of 2024 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global laboratory centrifuge market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
Table of Contents
158 Pages
- 1. Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Laboratory Centrifuge Market Sales Analysis - Product Type | Application | End-Users ($ Million)
- Laboratory Centrifuge Market Sales Performance of Top Countries
- 1.1. Research Methodology
- Primary Research Approach
- Secondary Research Approach
- 1.2. Market Snapshot
- 2. Market Overview and Insights
- 2.1. Scope of the Study
- 2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Laboratory Centrifuge Market Trends
- 2.2.2. Market Recommendations
- 2.3. Porter's Five Forces Analysis for the Laboratory Centrifuge Market
- 2.3.1. Competitive Rivalry
- 2.3.2. Threat of New Entrants
- 2.3.3. Bargaining Power of Suppliers
- 2.3.4. Bargaining Power of Buyers
- 2.3.5. Threat of Substitutes
- 3. Market Determinants
- 3.1. Market Drivers
- 3.1.1. Drivers For Global Laboratory Centrifuge Market: Impact Analysis
- 3.2. Market Pain Points and Challenges
- 3.2.1. Restraints For Global Laboratory Centrifuge Market: Impact Analysis
- 3.3. Market Opportunities
- 3.3.1. Opportunities For Global Laboratory Centrifuge Market: Impact Analysis
- 4. Competitive Landscape
- 4.1. Competitive Dashboard - Laboratory Centrifuge Market Revenue and Share by Manufacturers
- Laboratory Centrifuge Product Comparison Analysis
- Top Market Player Ranking Matrix
- 4.2. Key Company Analysis
- 4.2.1. Andreas Hettich GmbH & Co. KG
- 4.2.1.1. Overview
- 4.2.1.2. Product Portfolio
- 4.2.1.3. Financial Analysis
- 4.2.1.4. SWOT Analysis
- 4.2.1.5. Business Strategy
- 4.2.2. Danaher Corp.
- 4.2.2.1. Overview
- 4.2.2.2. Product Portfolio
- 4.2.2.3. Financial Analysis
- 4.2.2.4. SWOT Analysis
- 4.2.2.5. Business Strategy
- 4.2.3. Eppendorf AG
- 4.2.3.1. Overview
- 4.2.3.2. Product Portfolio
- 4.2.3.3. Financial Analysis
- 4.2.3.4. SWOT Analysis
- 4.2.3.5. Business Strategy
- 4.2.4. Sigma Laborzentrifugen GmbH
- 4.2.4.1. Overview
- 4.2.4.2. Product Portfolio
- 4.2.4.3. Financial Analysis
- 4.2.4.4. SWOT Analysis
- 4.2.4.5. Business Strategy
- 4.2.5. Thermo Fisher Scientific Inc.
- 4.2.5.1. Overview
- 4.2.5.2. Product Portfolio
- 4.2.5.3. Financial Analysis
- 4.2.5.4. SWOT Analysis
- 4.2.5.5. Business Strategy
- 4.3. Top Winning Strategies by Market Players
- 4.3.1. Merger and Acquisition
- 4.3.2. Product Launch
- 4.3.3. Partnership And Collaboration
- 5. Global Laboratory Centrifuge Market Sales Analysis by Product Type ($ Million)
- 5.1. Devices
- 5.2. Microcentrifuge
- 5.3. Multipurpose Centrifuge
- 5.4. Floor-Based Centrifuge
- 5.5. Ultracentrifuge
- 5.6. Accessories (Tubes, Centrifuge Bottles, Buckets, Plates)
- 6. Global Laboratory Centrifuge Market Sales Analysis by Application ($ Million)
- 6.1. Diagnostic
- 6.2. Microbiology
- 6.3. Genomics
- 6.4. Proteomics
- 6.5. Blood Component Separation
- 6.6. Others (Cellomics)
- 7. Global Laboratory Centrifuge Market Sales Analysis by End-Users($ Million)
- 7.1. Hospitals
- 7.2. Academic & Research Institutes
- 7.3. Biotechnology & Pharmaceutical Companies
- 8. Regional Analysis
- 8.1. North American Laboratory Centrifuge Market Sales Analysis - Product Type | Application | End-Users| Country ($ Million)
- Macroeconomic Factors for North America
- 8.1.1. United States
- 8.1.2. Canada
- 8.2. European Laboratory Centrifuge Market Sales Analysis - Product Type | Application | End-Users| Country ($ Million)
- Macroeconomic Factors for Europe
- 8.2.1. UK
- 8.2.2. Germany
- 8.2.3. Italy
- 8.2.4. Spain
- 8.2.5. France
- 8.2.6. Russia
- 8.2.7. Rest of Europe
- 8.3. Asia-Pacific Laboratory Centrifuge Market Sales Analysis - Product Type | Application | End-Users| Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
- 8.3.4. India
- 8.3.5. Australia & New Zealand
- 8.3.6. ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- 8.3.7. Rest of Asia-Pacific
- 8.4. Rest of the World Laboratory Centrifuge Market Sales Analysis - Product Type | Application | End-Users| Country ($ Million)
- Macroeconomic Factors for the Rest of the World
- 8.4.1. Latin America
- 8.4.2. Middle East and Africa
- 9. Company Profiles
- 9.1. Agilent Technologies
- 9.1.1. Quick Facts
- 9.1.2. Company Overview
- 9.1.3. Product Portfolio
- 9.1.4. Business Strategies
- 9.2. Andreas Hettich GmbH & Co. KG (Hettich Lab Technology)
- 9.2.1. Quick Facts
- 9.2.2. Company Overview
- 9.2.3. Product Portfolio
- 9.2.4. Business Strategies
- 9.3. Beckman Coulter (Danaher Corporation)
- 9.3.1. Quick Facts
- 9.3.2. Company Overview
- 9.3.3. Product Portfolio
- 9.3.4. Business Strategies
- 9.4. Benchmark Scientific
- 9.4.1. Quick Facts
- 9.4.2. Company Overview
- 9.4.3. Product Portfolio
- 9.4.4. Business Strategies
- 9.5. Bio-Rad Laboratories
- 9.5.1. Quick Facts
- 9.5.2. Company Overview
- 9.5.3. Product Portfolio
- 9.5.4. Business Strategies
- 9.6. Boekel Scientific
- 9.6.1. Quick Facts
- 9.6.2. Company Overview
- 9.6.3. Product Portfolio
- 9.6.4. Business Strategies
- 9.7. Eppendorf AG
- 9.7.1. Quick Facts
- 9.7.2. Company Overview
- 9.7.3. Product Portfolio
- 9.7.4. Business Strategies
- 9.8. Haier Biomedical
- 9.8.1. Quick Facts
- 9.8.2. Company Overview
- 9.8.3. Product Portfolio
- 9.8.4. Business Strategies
- 9.9. Heal Force Bio-Medical
- 9.9.1. Quick Facts
- 9.9.2. Company Overview
- 9.9.3. Product Portfolio
- 9.9.4. Business Strategies
- 9.10. Engineering Co., Ltd.
- 9.10.1. Quick Facts
- 9.10.2. Company Overview
- 9.10.3. Product Portfolio
- 9.10.4. Business Strategies
- 9.11. Kubota Corp.
- 9.11.1. Quick Facts
- 9.11.2. Company Overview
- 9.11.3. Product Portfolio
- 9.11.4. Business Strategies
- 9.12. Labnet International
- 9.12.1. Quick Facts
- 9.12.2. Company Overview
- 9.12.3. Product Portfolio
- 9.12.4. Business Strategies
- 9.13. PerkinElmer Inc.
- 9.13.1. Quick Facts
- 9.13.2. Company Overview
- 9.13.3. Product Portfolio
- 9.13.4. Business Strategies
- 9.14. QIAGEN.
- 9.14.1. Quick Facts
- 9.14.2. Company Overview
- 9.14.3. Product Portfolio
- 9.14.4. Business Strategies
- 9.15. REMI Group (REMI / REMI Elektrotechnik)
- 9.15.1. Quick Facts
- 9.15.2. Company Overview
- 9.15.3. Product Portfolio
- 9.15.4. Business Strategies
- 9.16. Sartorius AG
- 9.16.1. Quick Facts
- 9.16.2. Company Overview
- 9.16.3. Product Portfolio
- 9.16.4. Business Strategies
- 9.17. Scilogex
- 9.17.1. Quick Facts
- 9.17.2. Company Overview
- 9.17.3. Product Portfolio
- 9.17.4. Business Strategies
- 9.18. Shimadzu Corp.
- 9.18.1. Quick Facts
- 9.18.2. Company Overview
- 9.18.3. Product Portfolio
- 9.18.4. Business Strategies
- 9.19. Sigma Laborzentrifugen GmbH
- 9.19.1. Quick Facts
- 9.19.2. Company Overview
- 9.19.3. Product Portfolio
- 9.19.4. Business Strategies
- 9.20. Thermo Fisher Scientific
- 9.20.1. Quick Facts
- 9.20.2. Company Overview
- 9.20.3. Product Portfolio
- 9.20.4. Business Strategies
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
